Answers are grounded in this paper and cite their sources.
Recombinant human tumor necrosis factor alpha (rHuTNF-alpha) administered intravenously to mice resulted in enhanced resistance to a lethal challenge infection of Listeria monocytogenes given 24 h later. The observed protection was lost following treatment of the rHuTNF-alpha preparations with rabbit polyclonal antibody rHuTNF-alpha but not with normal rabbit immunoglobulin G.
No takes yet. Share an insight, caveat, or question.
Desiderio et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: